Columbia Partners Investment Management’s Regulus Therapeutics RGLS Stock Holding History

Columbia Partners Investment Management’s Portfolio RGLS Stock Details RGLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-553	Closed	-$219K	–	307
2016 Q3	$219K	Sell	553 -2,690	-83%	-$1.11M	0.02%	293
2016 Q2	$1.12M	Sell	3,243 -913	-22%	-$654K	0.08%	260
2016 Q1	$3.46M	Sell	4,156 -945	-19%	-$752K	0.25%	129
2015 Q4	$5.34M	Buy	5,101 +3,535	+226%	+$3.54M	0.37%	98
2015 Q3	$1.23M	Buy	+1,566	New	+$1.61M	0.09%	227

Other funds holding RGLS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SDIC

South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Columbia Partners Investment Management's RGLS Position: Q4 2016 in Review

Columbia Partners Investment Management sold out of Regulus Therapeutics (RGLS) in Q4 2016, closing a stake of 553 shares — an estimated $219K sold.

Columbia Partners Investment Management first reported a position in RGLS in Q3 2015 and held it in 5 quarters. The position peaked at $5.34M in Q4 2015. 68 funds tracked by Wall St. Rank hold RGLS as of Q4 2016.

Columbia Partners Investment Management reported no remaining Regulus Therapeutics position as of Q4 2016 after selling out during the quarter.
Columbia Partners Investment Management sold 553 Regulus Therapeutics shares in Q4 2016, an estimated $219K.
Columbia Partners Investment Management first reported a position in Regulus Therapeutics in Q3 2015 and held it in 5 quarters.
Columbia Partners Investment Management's Regulus Therapeutics position peaked at $5.34M in Q4 2015.
68 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q4 2016.

Based on Columbia Partners Investment Management's 13F filing for Q4 2016, filed 13 Feb 2017.